The Biden administration proposed a rule to let Medicare and Medicaid cover obesity drugs like Ozempic. Millions would ...

The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...

About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration ...

A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...

Federal law does not allow Medicare to pay for weight-loss medications, but the Biden administration categorizes obesity as a ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...

Weight-loss drugs like Ozempic and Zepbound would be covered by Medicare and Medicaid ... these drugs as treatments for ...